Blue Light Cystoscopy with Cysview for Bladder Cancer

Blue Light Cystoscopy With Cysview® Registry

Recruiting Observational Study
Bladder Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
4,400 (estimated)
Sponsor
Photocure · Industry
Who this trial is looking for

This trial is looking for adults with suspected or known non-muscle invasive bladder cancer. Participants will help gather information on the use of Blue Light Cystoscopy with Cysview in urologists' practices.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am over 18 years old
  • I have suspected or known non-muscle invasive bladder cancer

You may not be able to join if

  • I have porphyria
  • I have gross hematuria
  • I am known to be hypersensitive to hexaminolevulinate or aminolevulinate derivatives

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult \>18 years old * Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy Exclusion Criteria: * Porphyria * Gross hematuria * Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Contacts

Chad McKee, PhD

(919) 780-0417

chad.mckee@photocure.com

CONTACT